The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure.

AIMS Chronic heart failure (CHF) is a common and leading cause of death in industrialized countries. The potential benefits of micronutrient supplementation in CHF are extensive. Therefore, we examined the influence of long-term multiple micronutrient supplementation on left ventricular (LV) function, levels of pro-inflammatory cytokines, and quality-of-life (QoL) in elderly patients with CHF. METHODS AND RESULTS Thirty CHF patients [age 75.4 (0.7), mean (SEM), LV ejection fraction (LVEF) < or =35%] were randomized to receive capsules containing a combination of high-dose micronutrients (calcium, magnesium, zinc, copper, selenium, vitamin A, thiamine, riboflavin, vitamin B(6), folate, vitamin B(12), vitamin C, vitamin E, vitamin D, and Coenzyme Q10) or placebo for 9 months in a double-blind fashion. All subjects were on stable optimal medical therapy for at least 3 months before enrolment. At randomization and at study end, tumour necrosis factor-alpha and its soluble receptors TNFR-1 and TNFR-2 were measured and six-minute walk test and QoL were assessed. Cardiac magnetic resonance scanning was performed to evaluate cardiac dimensions and LVEF. Two patients died during follow-up. The remaining patients (14 randomized to placebo and 14 to micronutrients) were well matched for LV function, symptoms, and exercise capacity. At the end of the follow-up period, LV volumes were reduced in the intervention group with no change in the placebo group [-13.1 (17.1)% vs. +3.8 (10.0)%; P<0.05]. LVEF increased by 5.3+/-1.4% in the intervention group and was unchanged in the placebo group (P<0.05). Patients taking micronutrients also had a significant improvement in QoL score between enrolment and study end [+9.5 (1.6)%; P<0.05], whereas those taking placebo had a slight deterioration [-1.1 (0.8)%; P=0.12]. Six-minute walk test and inflammatory cytokine levels remained unchanged in both groups. CONCLUSION Long-term multiple micronutrient supplementation can improve LV volumes and LVEF and QoL scores in elderly patients with heart failure due to LV systolic dysfunction.

[1]  E. Rimm,et al.  Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. , 2004, The American journal of clinical nutrition.

[2]  J. Salonen,et al.  Serum folate and homocysteine and the incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. , 2004, The American journal of clinical nutrition.

[3]  W. Fawzi,et al.  A randomized trial of multivitamin supplements and HIV disease progression and mortality. , 2004, The New England journal of medicine.

[4]  Ph.D. Prof. S. Jameson M.D. Statistical data support prediction of death within 6 months on low levels of coenzyme Q10 and other entities , 2004, The clinical investigator.

[5]  M. Condorelli,et al.  Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study , 2004, The clinical investigator.

[6]  N. Freemantle,et al.  The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. , 2003, European heart journal.

[7]  N. Freemantle,et al.  The heart failure revascularisation trial (HEART): rationale, design and methodology , 2003, European journal of heart failure.

[8]  N. Freemantle,et al.  The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment , 2003 .

[9]  N Freemantle,et al.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. , 2003, European heart journal.

[10]  H. Krum,et al.  Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure , 2003, BioFactors.

[11]  C. R.J.,et al.  Statistics with Confidence (2nd ed.) , 2003 .

[12]  R. Collins,et al.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial , 2002 .

[13]  S. Stewart,et al.  Detecting early clinical deterioration in chronic heart failure patients post‐acute hospitalisation—a critical component of multidisciplinary, home‐based intervention? , 2002, European journal of heart failure.

[14]  F. Jeejeebhoy,et al.  Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction. , 2002, American heart journal.

[15]  A. Coats MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002 .

[16]  J. Steghens,et al.  Dietary and blood antioxidants in patients with chronic heart failure. Insights into the potential importance of selenium in heart failure , 2001, European journal of heart failure.

[17]  A. Zeiher,et al.  Vitamin C Inhibits Endothelial Cell Apoptosis in Congestive Heart Failure , 2001, Circulation.

[18]  P. Poole‐Wilson,et al.  Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. , 2001, European heart journal.

[19]  Judea Pearl,et al.  Direct and Indirect Effects , 2001, UAI.

[20]  J. Cleland,et al.  Chronic heart failure and micronutrients. , 2001, Journal of the American College of Cardiology.

[21]  Kukin Ml The Heart Outcomes Prevention Evaluation Study. , 2001, Current cardiology reports.

[22]  A. Langer,et al.  A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure. , 2001, The American journal of clinical nutrition.

[23]  J. Cockcroft,et al.  Vitamin C acutely improves ejection duration in chronic heart failure (CHF) patients in a heart rate independent fashion , 2000 .

[24]  Joanne Eastaugh,et al.  The Euro Heart Failure Survey of The EUROHEART Survey Programme: A survey on the quality of care among patients with heart failure in Europe , 2000, European journal of heart failure.

[25]  M. Fisher,et al.  The Effect of Coenzyme Q10 in Patients with Congestive Heart Failure , 2000, Annals of Internal Medicine.

[26]  P. Langsjoen Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure. , 2000, Journal of the American College of Cardiology.

[27]  S. Yusuf,et al.  Vitamin E supplementation and cardiovascular events in high-risk patients. , 2000, The New England journal of medicine.

[28]  M. Smithson Statistics with confidence , 2000 .

[29]  S. Yusuf,et al.  Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53. , 2000 .

[30]  D J Pennell,et al.  Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. , 2000, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[31]  Y. J. Kang The antioxidant function of metallothionein in the heart. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[32]  GISSI-Prevenzione Investigators,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.

[33]  Roberto Marchioli,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. , 1999 .

[34]  D. Burstow,et al.  Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure. , 1999, Journal of the American College of Cardiology.

[35]  P. Poole‐Wilson,et al.  Successes and failures of current treatment of heart failure , 1998, The Lancet.

[36]  J. Cleland,et al.  Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995. , 1998, European heart journal.

[37]  A. Omran,et al.  Increased oxidative stress in patients with congestive heart failure. , 1998, Journal of the American College of Cardiology.

[38]  T. Perneger What's wrong with Bonferroni adjustments , 1998, BMJ.

[39]  H. Drexler,et al.  Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. , 1998, Circulation.

[40]  T. Imaizumi,et al.  Oxidative stress is related to exercise intolerance in patients with heart failure. , 1998, American heart journal.

[41]  S. W. May,et al.  Selenium-based antihypertensives. Rationale and potential. , 1998, Drugs.

[42]  G. Plotnick,et al.  Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. , 1997, JAMA.

[43]  E. Braunwald Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.

[44]  S. Mortensen,et al.  Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials. , 1997, Molecular aspects of medicine.

[45]  M. Motro,et al.  Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. , 1995, The American journal of medicine.

[46]  K. Swedberg,et al.  Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 Study Group. , 1995, Journal of cardiac failure.

[47]  R. Barbour,et al.  Ferrylmyoglobin formation induced by acute magnesium deficiency in perfused rat heart causes cardiac failure. , 1994, Biochimica et biophysica acta.

[48]  A. Favier,et al.  Effect of zinc deficiency on lipid peroxidation status and infarct size in rat hearts. , 1993, International journal of cardiology.

[49]  J. McMurray,et al.  Trends in hospitalization for heart failure in Scotland 1980-1990. , 1993, European heart journal.

[50]  J. Stamler,et al.  Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. , 1993, The Journal of clinical investigation.

[51]  I Russell,et al.  Statistics--with confidence? , 1991, The British journal of general practice : the journal of the Royal College of General Practitioners.

[52]  A. Stewart,et al.  Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. , 1989, JAMA.

[53]  William H. Rogers,et al.  Functional Status and Well-Being of Patients with Chronic Conditions , 1989 .

[54]  R. Simpson,et al.  Involvement of vitamin D3 with cardiovascular function. II. Direct and indirect effects. , 1987, The American journal of physiology.

[55]  G. Guyatt,et al.  The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. , 1985, Canadian Medical Association journal.